HEATHER THOMPSON: Open Payments
NPI 1235808544 · LULING, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 35 payments from 9 companies in 2025. Trend: 2023 $1,179 · 2024 $1,065 · 2025 $651
Food & beverage: $649Education: $1
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $162 |
| Vanda Pharmaceuticals Inc. | 9 | $148 |
| Alkermes, Inc. | 6 | $136 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VRAYLAR, FANAPT, ARISTADA, Auvelity, SPRAVATO, CAPLYTA, REXULTI, MOUNJARO.
Industry payments across LA — which companies pay providers there.
